MD Anderson Cancer Center
Research aims to capture, interrogate single cancer cells
Nicholas Navin, Ph.D., of MD Anderson’s Genetics Department, has a plan to sort out the genetic differences among individual tumor cells at different stages of cancer development, then analyze and compare their active mutations. The results should track the evolution of triple-negative breast cancer from initial tumor to circulating tumor cell to metastatic cell. This new approach, funded by the Damon Runyon Cancer Research Foundation, would make it easier to predict tumor invasion, its spread to other organs, patient survival and response to chemotherapy.
Video is loading...
Title: Research aims to capture, interrogate single cancer cells
Summary: Nicholas Navin, Ph.D., of MD Anderson’s Genetics Department, has a plan to sort out the genetic differences among individual tumor cells at different stages of cancer development, then analyze and compare their active mutations. The results should track the evolution of triple-negative breast cancer from initial tumor to circulating tumor cell to metastatic cell. This new approach, funded by the Damon Runyon Cancer Research Foundation, would make it easier to predict tumor invasion, its spread to other organs, patient survival and response to chemotherapy.
Keywords: Comm, Communications
Transcript: